About us

Glycotope is a clinical stage immuno-oncology company built on world-leading glycobiology expertise. A set of our highly innovative clinical and pre-clinical projects with focus on oncology/immuno-oncology are available for partnering. The Company has a mature and growing pipeline of proprietary cancer therapies.
The GlycoBody platform generates highly specific mAbs against carbohydrate epitopes found only on tumor cells.

Pharmaceutical Service:
In addition, Glycotope offers a wide range of service in Cell Line and Process Development with our innovative GlycoExpress® technology, as well as Analytical services, Glycan- and Protein analysis and Clinical Immunomonitoring. For more information please visit https://www.glycotope.com/biopharmaceuticals-services/

Products and services

Glycotope offers a wide range of service in Cell Line and Process Development with our innovative GlycoExpress® technology, as well as Analytical services, Glycan- and Protein analysis and Clinical Immunomonitoring.
For more information please visit: https://www.glycotope.com/biopharmaceuticals-services/

Address
Glycotope GmbH
Robert-Roessle-Str. 10
13125 Berlin
Germany

Phone: +49 30 94892600
Internet: www.glycotope.com
E-mail: Send message

Contact person

Lars Stöckl
Division Manager
Phone: +49 176 19489823
E-mail: Send message

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection